What we have learned from crystal structures of proteins to receptor function

Area of Science:

• Neuroscience
• Structural Biology
• Computational Chemistry

Background:

• Ligand-gated ion channels are critical for brain function, and their dysfunction is linked to neurological diseases like epilepsy.
• Advances in molecular biology and crystallography have provided atomic-level insights into these channels and related proteins.
• Understanding ligand-binding pockets enables computational approaches for drug discovery.

Purpose of the Study:

• To discuss the potential and limitations of using structural information of ligand-gated channels with virtual screening and functional assays.
• To identify novel compounds targeting ligand-gated channels.
• To explore strategies for developing more effective modulators of channel activity.

Main Methods:

• Utilized atomic-scale structural data from crystallography of ligand-gated channels and binding proteins.
• Employed virtual screening approaches, including docking against large chemical databases like GDB-11.
• Synthesized and characterized identified molecules using binding assays and determined their pose in crystal structures.

Main Results:

• Virtual screening identified molecules that were synthesized and tested.
• Functional studies revealed that some identified molecules acted as open channel blockers rather than binding site antagonists.
• Crystal structures aided in understanding molecular interactions but highlighted challenges in achieving desired binding specificities.

Conclusions:

• Structural insights into ligand-gated channels are valuable for drug discovery.
• Current virtual screening methods combined with structural data show promise but face limitations in targeting specific binding sites.
• Further integration of structural, computational, and functional approaches is needed to discover novel, specific channel modulators.